The impact of duration of treatment on reported time-to-onset in spontaneous reporting systems for pharmacovigilance.
Within pharmacovigilance, knowledge of time-to-onset (time from start of drug administration to onset of reaction) is important in causality assessment of drugs and suspected adverse drug reactions (ADRs) and may indicate pharmacological mechanisms involved. It has been suggested that time-to-onset...
Guardado en:
Autores principales: | Ghazaleh Karimi, Kristina Star, G Niklas Norén, Staffan Hägg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5a773b0971f442988c68a22cfee43a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Quality assessment of individual case safety reports in pharmacovigilance in Burkina Faso
por: Roamba Nazaire, et al.
Publicado: (2021) -
Pharmacovigilance in Covid-19 vaccines
por: Bahouq Hanane, et al.
Publicado: (2021) -
Pharmacovigilance of quality deviations in the public healthcare system
por: Carolina Resende Bitencourt, et al.
Publicado: (2019) -
Gathering and exploring scientific knowledge in pharmacovigilance.
por: Pedro Lopes, et al.
Publicado: (2013) -
A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data
por: Bin Wu, et al.
Publicado: (2021)